We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$6.85B
AUM Growth
+$678M
Cap. Flow
-$555M
Cap. Flow %
-8.1%
Top 10 Hldgs %
43.77%
Holding
155
New
30
Increased
19
Reduced
23
Closed
29

Top Buys

Rank Stock Value
1
OM icon
Outset Medical
OM
+$156M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$119M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$90.9M
4
RLAY icon
Relay Therapeutics
RLAY
+$88.8M
5
CHRS icon
Coherus Oncology
CHRS
+$57.5M

Top Sells

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$133M
2
KOD icon
Kodiak Sciences
KOD
+$124M
3
NBIX icon
Neurocrine Biosciences
NBIX
+$68.6M
4
VAPO
Vapotherm, Inc. Common Stock
VAPO
+$54.9M
5
IOVA icon
Iovance Biotherapeutics
IOVA
+$52.8M

Sector Composition

Rank Sector Weight
1 Healthcare 84.2%
2 Miscellaneous 14.63%
3 Consumer Staples 0.6%
4 Financials 0.25%
5 Industrials 0.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDMN
26
DELISTED
Kadmon Holdings, Inc.
KDMN
$61.6M 0.9%
15,711,334
– –
TVTX icon
27
Travere Therapeutics
TVTX
$5.89B
$59.8M 0.87%
3,240,112
– –
NARI
28
DELISTED
Inari Medical, Inc. Common Stock
NARI
$58.6M 0.86%
848,500
+152,500
+22% +$9.81M
LONA
29
LeonaBio Inc
LONA
$68.2M
$57.5M 0.84%
+311,481
New +$52M
CRNX
30
DELISTED
Crinetics Pharmaceuticals
CRNX
$57.3M 0.84%
3,659,381
– –
PRVB
31
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$54.7M 0.8%
4,265,711
-260,000
-6% -$3.28M
RCKT icon
32
Rocket Pharmaceuticals
RCKT
$374M
$50M 0.73%
2,189,010
– –
IMVT icon
33
Immunovant
IMVT
$7.57B
$49.3M 0.72%
1,400,000
+300,000
+27% +$9.02M
AGRX
34
DELISTED
Agile Therapeutics
AGRX
$48.4M 0.71%
7,960
– –
ARNA
35
DELISTED
Arena Pharmaceuticals Inc
ARNA
$46.8M 0.68%
625,129
-470,000
-43% -$31.3M
ALDX icon
36
Aldeyra Therapeutics
ALDX
$82.6M
$46.6M 0.68%
6,285,458
+3,200,000
+104% +$20.7M
ALLO icon
37
Allogene Therapeutics
ALLO
$594M
$43.1M 0.63%
1,143,790
-400,000
-26% -$15.1M
COLL icon
38
Collegium Pharmaceutical
COLL
$711M
$42.8M 0.63%
2,058,068
– –
PCVX icon
39
Vaxcyte
PCVX
$8.81B
$42M 0.61%
850,000
– –
NEPT
40
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$41M 0.6%
13,884
+715
+5% +$2.72M
ADPT icon
41
Adaptive Biotechnologies
ADPT
$4.26B
$40.4M 0.59%
830,000
+350,000
+73% +$14.7M
ADMA icon
42
ADMA Biologics
ADMA
$1.93B
$39.6M 0.58%
16,584,802
– –
YARW
43
Yarrow Bioscience
YARW
$68.1M
$38M 0.55%
6,355
– –
CMPS
44
Compass Pathways
CMPS
$1.91B
$36.6M 0.53%
+1,047,404
New +$37.7M
LYRA
45
DELISTED
LYRA THERAPEUTICS INC
LYRA
$36M 0.53%
64,451
– –
SILK
46
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$35M 0.51%
520,100
+135,000
+35% +$7.37M
RNAM
47
DELISTED
Avidity Biosciences
RNAM
$34.8M 0.51%
1,235,818
– –
EIDX
48
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$34.7M 0.51%
686,922
– –
ZNTL icon
49
Zentalis Pharmaceuticals
ZNTL
$296M
$34.3M 0.5%
1,050,003
– –
MGNX icon
50
MacroGenics
MGNX
$257M
$32.5M 0.47%
1,291,181
+3,167
+0.2% +$86.5K
1
2
3 4 5

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Perceptive Advisors held 155 positions worth $6.85B, up 11% from $6.17B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Perceptive Advisors withdrew a net $555M in Q3 2020, closing 29 positions and reducing 23 holdings. Its most notable exit was Zogenix, Inc., an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 84% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Perceptive Advisors opened a new position in Outset Medical worth $142M.

  • Perceptive Advisors's largest Q3 2020 buy was Outset Medical: 189,855 shares worth $142M.
  • Perceptive Advisors added most to Mirati Therapeutics, Inc. Common Stock in Q3 2020, an estimated $90.9M increase.
  • Perceptive Advisors's biggest Q3 2020 reduction was Kodiak Sciences, cutting an estimated $124M.
  • Perceptive Advisors fully exited Zogenix, Inc. in Q3 2020, selling an estimated $133M.
  • Perceptive Advisors's ten largest holdings make up 44% of its $6.85B portfolio in Q3 2020.
  • Perceptive Advisors opened 30 new positions and closed 29 in Q3 2020.
  • Perceptive Advisors's portfolio value rose 11% quarter-over-quarter to $6.85B.

Based on Perceptive Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.